<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article article-type="research-article" dtd-version="3.0" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0153188</article-id>
<article-id pub-id-type="publisher-id">PONE-D-15-46340</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Sepsis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Sepsis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Mathematical and statistical techniques</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Statistics (mathematics)</subject><subj-group><subject>Statistical methods</subject><subj-group><subject>Meta-analysis</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Biomarkers</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Sepsis</subject><subj-group><subject>Systemic inflammatory response syndrome</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Sepsis</subject><subj-group><subject>Systemic inflammatory response syndrome</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Research assessment</subject><subj-group><subject>Systematic reviews</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Database and informatics methods</subject><subj-group><subject>Database searching</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune response</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Inflammation</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Diagnostic Accuracy of Lipopolysaccharide-Binding Protein as Biomarker for Sepsis in Adult Patients: A Systematic Review and Meta-Analysis</article-title>
<alt-title alt-title-type="running-head">Diagnostic Accuracy of LBP as Biomarker for Sepsis: A Systematic Review and Meta-Analysis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chen</surname>
<given-names>Kuan-Fu</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Chaou</surname>
<given-names>Chung-Hsien</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jiang</surname>
<given-names>Jing-Yi</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Yu</surname>
<given-names>Hsueh-Wen</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Meng</surname>
<given-names>Yu-Hsiang</given-names>
</name>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Tang</surname>
<given-names>Wei-Chen</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Wu</surname>
<given-names>Chin-Chieh</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Department of Emergency Medicine, Chang Gung Memorial Hospital, Keelung, Taiwan</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Clinical Informatics and Medical Statistics Research Center, Chang Gung University, Taoyuan, Taiwan</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Community Medicine Research Center, Chang Gung Memorial Hospital, Keelung, Taiwan</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Emergency Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>School of Traditional Chinese Medicine, Chang Gung University, Taoyuan, Taiwan</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>School of Medicine, Chang Gung University, Taoyuan, Taiwan</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Thombs</surname>
<given-names>Brett D</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>McGill University, CANADA</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: KFC CCW. Performed the experiments: JYJ HWY CHC YHM. Analyzed the data: KFC CCW. Contributed reagents/materials/analysis tools: JYJ HWY CHC YHM WCT. Wrote the paper: KFC CCW. Quality assessment: CCW WCT.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">wujinja@cgmh.org.tw</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>7</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>11</volume>
<issue>4</issue>
<elocation-id>e0153188</elocation-id>
<history>
<date date-type="received">
<day>6</day>
<month>12</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>3</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Chen et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0153188"/>
<abstract>
<sec id="sec001">
<title>Introduction</title>
<p>Lipopolysaccharide-binding protein (LBP) is widely reported as a biomarker to differentiate infected from non-infected patients. The diagnostic use of LBP for sepsis remains a matter of debate. We aimed to perform a systematic review and meta-analysis to assess the diagnostic accuracy of serum LBP for sepsis in adult patients.</p>
</sec>
<sec id="sec002">
<title>Methods</title>
<p>We performed a systematic review and meta-analysis to assess the accuracy of LBP for sepsis diagnosis. A systematic search in PubMed and EMBASE for studies that evaluated the diagnostic role of LBP for sepsis through December 2015 was conducted. We searched these databases for original, English language, research articles that studied the diagnostic accuracy between septic and non-septic adult patients. Sensitivity, specificity, and other measures of accuracy, such as diagnostic odds ratio (DOR) and area under the receiver operating characteristic curve (AUC) of LBP were pooled using the Hierarchical Summary Receiver Operating Characteristic (HSROC) method.</p>
</sec>
<sec id="sec003">
<title>Results</title>
<p>Our search returned 53 reports, of which 8 fulfilled the inclusion criteria, accounting for 1684 patients. The pooled sensitivity and specificity of LBP for diagnosis of sepsis by the HSROC method were 0.64 (95% CI: 0.56–0.72) and 0.63 (95% CI: 0.53–0.73), respectively. The value of the DOR was 3.0 (95% CI: 2.0–4.0) and the AUC was 0.68 (95% CI: 0.64–0.72). Meta-regression analysis revealed that cut-off values accounted for the heterogeneity of sensitivity and sample size (&gt; = 150) accounted for the heterogeneity of specificity.</p>
</sec>
<sec id="sec004">
<title>Conclusions</title>
<p>Based on the results of our meta-analysis, LBP had weak sensitivity and specificity in the detection of sepsis. LBP may not be practically recommended for clinical utilization as a single biomarker.</p>
</sec>
</abstract>
<funding-group>
<funding-statement>National Science Council (grant number: NMRPG2A6011) Chang Gung Memorial Hospital in Taiwan (grant number: 100-2314-B-182A-038-MY3, CMRPG2C0201, CMRPG2B0121, CMRPG2B0271 and CMRPG2B0371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="3"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec005" sec-type="intro">
<title>Introduction</title>
<p>Despite the recent focus on the importance of early and effective therapy for sepsis in past decades, this fatal disease still poses a burden to critically ill populations worldwide [<xref ref-type="bibr" rid="pone.0153188.ref001">1</xref>]. One of the main reasons first-line health care providers fail to provide timely and accurate care to patients with sepsis is the lack of rapid and accurate diagnostic aids. During the past decade, even with the abundant progress made in the field of molecular biology, clinicians still rely on microbiological culture as the conventional reference standard to distinguish sepsis from non-infectious conditions. These cultures can take days to receive results, and lack sensitivity. Thus, there is an urgent need for a rapid, simple, and accurate method to enhance sepsis diagnosis.</p>
<p>Lipopolysaccharide (LPS)-binding protein (LBP) was initially discovered as an acute-phase reactant binding with the LPS of Gram-negative bacteria walls to form LPS-LBP complexes [<xref ref-type="bibr" rid="pone.0153188.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0153188.ref003">3</xref>] and was later found to be elevated in gram-positive bacteremia [<xref ref-type="bibr" rid="pone.0153188.ref004">4</xref>]. The LPS-LBP complex binds to CD14 and to the Toll-like receptor 4/MD2-complex and results in transcription of cytokines and other pro-inflammatory mediators [<xref ref-type="bibr" rid="pone.0153188.ref005">5</xref>, <xref ref-type="bibr" rid="pone.0153188.ref006">6</xref>]. Interestingly, LBP is constitutively present at a concentration of 5 to 10 μg/ml in healthy human serum [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>].</p>
<p>During sepsis, LBP levels were found to increase to median peak levels of 30–40 μg/ml within 24 h, almost seven times higher than normal levels [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>–<xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>]. These properties made LBP a promising tool for the diagnosis of sepsis, and suitable to discriminate between non-septic systemic inflammatory response syndrome (SIRS) and sepsis [<xref ref-type="bibr" rid="pone.0153188.ref010">10</xref>]. However, further studies indicate that LBP is a rather non-specific marker for inflammatory response [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>]. Whether LBP is appropriate for use as a clinical diagnostic tool for the differentiation between infectious and noninfectious etiologies of SIRS is still uncertain [<xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>].</p>
<p>Recently, several studies have investigated the role of serum LBP in differentiating sepsis from non-infectious SIRS in different clinical settings [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>–<xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>]. However, due to the limited sample size recruited in these studies, the results are not consistent. Therefore, we aimed to perform a systematic review and meta-analysis to assess the diagnostic accuracy of serum LBP for sepsis in adult patients.</p>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Methods and Materials</title>
<sec id="sec007">
<title>Literature Search Strategy</title>
<p>A protocol was developed prior to the conduction of this systematic review and meta-analysis. We conducted a comprehensive systematic search in PubMed and EMBASE for studies that evaluated the diagnostic accuracy of LBP for sepsis through December 2015. The following keywords were used: ((“Systemic Inflammatory Response Syndrome” OR “SIRS”) AND “Sepsis”) AND (“Early Diagnosis” OR “Diagnosis”) AND “Lipopolysaccharide-binding protein” AND “adult” in PubMed and (sensitivity OR diagnostic AND accuracy:lnk OR diagnostic AND ('sepsis'/exp OR sepsis) AND (' LBP' OR LBP) AND [english]/lim) in EMBASE. We searched these databases for original, English language, research articles that studied the diagnostic accuracy between septic and non-septic in adult patients. Further data was uncovered through review of the reference lists from the primary articles, and Google searches.</p>
</sec>
<sec id="sec008">
<title>Study Selection</title>
<p>After the removal of duplicate references, two reviewers (JYJ, and HWY) independently screened, and decided the inclusion of studies in this review using the following inclusion criteria: (1) sepsis related biomarker studies; (2) diagnostic instead of prognostic studies: e.g. studies on the diagnosis of sepsis instead of those on mortality prediction; and (3) articles in English. Studies were independently excluded based on the following exclusion criteria: (1) non-sepsis biomarker related study; (2) non-diagnostic study; (3) non-original study: e.g. literature review, editorial piece; (4) no performance parameters given (i.e. sensitivity, specificity, and 2x2 contingency tables). The Cohen’s Kappa statistic [<xref ref-type="bibr" rid="pone.0153188.ref017">17</xref>] was evaluated for the agreement with study inclusion.</p>
</sec>
<sec id="sec009">
<title>Data Extraction</title>
<p>Two reviewers (JYJ, and HWY) independently extracted all relevant information from each study such as study setting, material and method, statistical method, and the results via electrical form (Microsoft Access). We abstracted the numbers of true-positive, false-positive, false-negative, and true-negative based on the provided indices of sensitivity, specificity, and sample size values.</p>
</sec>
<sec id="sec010">
<title>Quality Assessment</title>
<p>The Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) checklist [<xref ref-type="bibr" rid="pone.0153188.ref018">18</xref>] was used to assess the methodological quality of included studies. QUADAS-2 is a four-domain tool, including patient selection, index test, reference standard, flow and timing, to assists authors of systematic reviews in rating the risk of bias and the applicability of diagnostic accuracy from their studies. Each domain is assessed in terms of risk of bias, and the first three domains are also assessed regarding applicability. Signaling questions are included to help judge risk of bias. For both categories, risk of bias and applicability, and the individual criteria was classified as low risk, high risk, or unclear. If and only if the answers to all questions of a domain were judged as “yes” indicating low risk of bias, then this domain was judged to be at “low” risk of bias. If any question of a domain was judged as “unclear,” then the domain would be judged as “unclear”. Two of the authors (CCW and WCT) assessed risk of bias independently, and discrepant results were resolved in a consensus meeting. Agreement between the two reviewers for assessment of methodological quality was evaluated using the Cohen’s Kappa statistic [<xref ref-type="bibr" rid="pone.0153188.ref017">17</xref>]. Subgroup analysis was conducted subsequently according to the results of the methodological quality assessment. Consensus meetings solved all discrepant results.</p>
</sec>
<sec id="sec011">
<title>Data synthesis and Statistical Analysis</title>
<p>We calculated the pooled sensitivity and specificity, diagnostic odds ratio (DOR) and the area under the receiver operating characteristic curve (AUC) based on the Hierarchical Summary Receiver Operating Characteristic (HSROC) method for meta-analysis of diagnostic test data [<xref ref-type="bibr" rid="pone.0153188.ref019">19</xref>]. It is believed that this approach could maximize use of the available data from each study, irrespective of the threshold used. We also constructed the respective summary receiver operating characteristic curves (SROC) [<xref ref-type="bibr" rid="pone.0153188.ref020">20</xref>] and calculated the AUC, irrespective of the different cut-off points used. For heterogeneity, it can be caused by two effects, threshold and non-threshold. For threshold effect, it was the calculation of spearman correlation coefficient (ρ) between logarithms of sensitivity and (1-specificity). Furthermore, for non-threshold effect, it was quantified by applying the chi-square (χ<sup>2</sup>) and the Cochrane-Q test (for DOR) and by determining the <italic>I</italic><sup>2</sup> metric [<xref ref-type="bibr" rid="pone.0153188.ref021">21</xref>]. Owing to the high statistical heterogeneity found among these studies, we performed univariable meta-regression analyses using a bivariate model
<disp-formula id="pone.0153188.e001">
<alternatives>
<graphic id="pone.0153188.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0153188.e001" xlink:type="simple"/>
<mml:math display="block" id="M1">
<mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mn>01</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mn>11</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
<disp-formula id="pone.0153188.e002">
<alternatives>
<graphic id="pone.0153188.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pone.0153188.e002" xlink:type="simple"/>
<mml:math display="block" id="M2">
<mml:mrow><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mn>02</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mrow><mml:mn>12</mml:mn></mml:mrow></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow>
</mml:math>
</alternatives>
</disp-formula>
to find the source of variability by potential factors. Meta-regression is a sophisticated tool for exploring heterogeneity. It aims to discern whether a linear relationship exists between an outcome measure and one or more covariates. The associations found in a meta-regression should be considered hypothesis generating and not regarded as proof of causality. We subsequently conducted subgroup analyses for studies with adequate number (more than three required for HSROC). Given the possibility of a small number of included studies, we also planned to perform subgroup analyses for covariates that were deemed to be clinically significant as predictors of accuracy, in order to avoid the low statistical power of the meta-regression. To test for possible publication bias, we constructed Deeks’ effective sample size funnel plots versus the diagnostic odds ratio and did a regression test of asymmetry. All statistical tests were two-sided and statistical significance was defined as <italic>p</italic>-value&lt;0.05. The Midas module for Stata 13.1 (Stata Corporation, College Station, TX, USA) was used for all statistical and meta-analyses. We used mada package in R (version 3.1.3) to complete the bivariate binomial mixed-effect meta-regression model. Midas and the QUADAS modules for Stata were used for all graphical displays of the quality of the included studies.</p>
</sec>
</sec>
<sec id="sec012" sec-type="results">
<title>Results</title>
<sec id="sec013">
<title>Identification of studies</title>
<p>Overall, our electronic search yielded 53 published studies, among them, one from the Google searching and another from the reference lists. After excluding 44 studies irrelevant to this review by screening titles and abstracts (six duplicates, 19 non-sepsis biomarker related studies, 13 non-diagnostic studies, one non-original editorial piece, three studies without performance parameters given, and two confidence proceedings), nine studies with available full-text were included for further data extraction procedures. Having reviewed the full text of the remaining nine articles, we then excluded another study for lack of information available to make a 2x2 contingency table for comparisons. Finally, eight eligibility studies were included in the analysis [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>–<xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] (<xref ref-type="fig" rid="pone.0153188.g001">Fig 1</xref>). The Cohen’s Kappa statistic evaluated agreement on study inclusion was 0.94 (95% CI: 0.83–1.00), indicating almost perfect inter-rater agreement.</p>
<fig id="pone.0153188.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153188.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Study identification, inclusion, and exclusion for meta-analysis.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec014">
<title>Study characteristics</title>
<p>The main characteristics of included studies are summarized in <xref ref-type="table" rid="pone.0153188.t001">Table 1</xref>. Of the 1684 patients included in our study, 486 (29%) were hospitalized in ICUs, 746 (44%) were admitted in the EDs, 452 (27%) were admitted in the general wards, 506 (30%) had sepsis, 308 (18.29%) had SIRS, and 1140 (51.71%) were normal healthy controls. All studies were conducted prospectively, and all studies used a case-control design. Regarding the reference tests, seven studies [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>–<xref ref-type="bibr" rid="pone.0153188.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0153188.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] defined the ‘gold standard’ by the criteria defined in the 1992 ACCP/SCCM consensus conference [<xref ref-type="bibr" rid="pone.0153188.ref022">22</xref>], and one [<xref ref-type="bibr" rid="pone.0153188.ref014">14</xref>] by blood culture. The proportion of patients with sepsis among studies ranged widely from 16% to 87% (mean 33%, <xref ref-type="table" rid="pone.0153188.t001">Table 1</xref>). The year of study conducted ranged from 2003 to 2013. For the types of specimen tested for LBP detection, five [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0153188.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] were serum, three [<xref ref-type="bibr" rid="pone.0153188.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0153188.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0153188.ref015">15</xref>] were plasma. All studies used the chemiluminescent LBP assay.</p>
<table-wrap id="pone.0153188.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153188.t001</object-id>
<label>Table 1</label> <caption><title>Main Characteristics of Selected Studies.</title></caption>
<alternatives>
<graphic id="pone.0153188.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center">Author, year</th>
<th align="center">Study design</th>
<th align="center">Mean age (years) Total or Case/ Control</th>
<th align="center">Patient source</th>
<th align="center">Case/ Control (n)</th>
<th align="center">Total (n)</th>
<th align="center">Proportion of patients with sepsis (%)</th>
<th align="center">Specimen tested</th>
<th align="center">Cut-off (μg/ml)</th>
<th align="center">Sensitivity, specificity</th>
<th align="center">TP(n) (%)</th>
<th align="center">FP(n) (%)</th>
<th align="center">FN(n) (%)</th>
<th align="center">TN(n) (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center"><bold>Gaini, S., et al., 2007 [</bold><xref ref-type="bibr" rid="pone.0153188.ref015">15</xref><bold>]</bold></td>
<td align="center">Prospective</td>
<td align="center">56.8/56.9</td>
<td align="center">General Ward</td>
<td align="center">134/20</td>
<td align="center">154</td>
<td align="center">87</td>
<td align="center">Plasma</td>
<td align="center">64.6</td>
<td align="center">0.79, 0.5</td>
<td align="center">106 (68.8)</td>
<td align="center">10 (6.5)</td>
<td align="center">28 (18.2)</td>
<td align="center">10 (6.5)</td>
</tr>
<tr>
<td align="center"><bold>Gille-Johnson, P., et al., 2012 [</bold><xref ref-type="bibr" rid="pone.0153188.ref014">14</xref><bold>]</bold></td>
<td align="center">Prospective</td>
<td align="center">61</td>
<td align="center">ED</td>
<td align="center">118/286</td>
<td align="center">404</td>
<td align="center">29</td>
<td align="center">Serum LBP</td>
<td align="center">36</td>
<td align="center">0.76, 0.45</td>
<td align="center">90 (22.3)</td>
<td align="center">157 (38.9)</td>
<td align="center">28 (6.9)</td>
<td align="center">129 (31.9)</td>
</tr>
<tr>
<td align="center"><bold>Meynaar, I.A., et al., 2011 [</bold><xref ref-type="bibr" rid="pone.0153188.ref016">16</xref><bold>]</bold></td>
<td align="center">Prospective</td>
<td align="center">68/65</td>
<td align="center">ICU</td>
<td align="center">32/44</td>
<td align="center">76</td>
<td align="center">42</td>
<td align="center">Serum LBP</td>
<td align="center">30</td>
<td align="center">0.53, 0.91</td>
<td align="center">17 (22.4)</td>
<td align="center">4 (5.3)</td>
<td align="center">15 (19.7)</td>
<td align="center">40 (52.6)</td>
</tr>
<tr>
<td align="center"><bold>Nierhaus, A., et al., 2013 [</bold><xref ref-type="bibr" rid="pone.0153188.ref011">11</xref><bold>]</bold></td>
<td align="center">Prospective</td>
<td align="center">52.9</td>
<td align="center">ICU</td>
<td align="center">51/19</td>
<td align="center">70</td>
<td align="center">73</td>
<td align="center">Serum LBP</td>
<td align="center">Not provided</td>
<td align="center">0.67, 0.64</td>
<td align="center">34 (48.6)</td>
<td align="center">8 (11.4)</td>
<td align="center">17 (24.3)</td>
<td align="center">11 (15.7)</td>
</tr>
<tr>
<td align="center"><bold>Prucha, M., et al., 2003 [</bold><xref ref-type="bibr" rid="pone.0153188.ref009">9</xref><bold>]</bold></td>
<td align="center">Prospective</td>
<td align="center">45.2/49.7</td>
<td align="center">ICU</td>
<td align="center">28/40</td>
<td align="center">68</td>
<td align="center">41</td>
<td align="center">Serum LBP</td>
<td align="center">29.8</td>
<td align="center">0.50, 0.74</td>
<td align="center">14 (20.6)</td>
<td align="center">10 (14.7)</td>
<td align="center">14 (20.6)</td>
<td align="center">30 (44.1)</td>
</tr>
<tr>
<td align="center"><bold>Ratzinger, F., et al., 2013 [</bold><xref ref-type="bibr" rid="pone.0153188.ref012">12</xref><bold>]</bold></td>
<td align="center">Prospective</td>
<td align="center">58/60</td>
<td align="center">General Ward</td>
<td align="center">75/223</td>
<td align="center">298</td>
<td align="center">25</td>
<td align="center">Plasma</td>
<td align="center">18.2</td>
<td align="center">0.58, 0.67</td>
<td align="center">43 (14.4)</td>
<td align="center">73 (24.5)</td>
<td align="center">32 (10.7)</td>
<td align="center">150 (50.4)</td>
</tr>
<tr>
<td align="center"><bold>Sakr, Y., et al., 2008 [</bold><xref ref-type="bibr" rid="pone.0153188.ref007">7</xref><bold>]</bold></td>
<td align="center">Prospective</td>
<td align="center">63</td>
<td align="center">ICU</td>
<td align="center">64/208</td>
<td align="center">272</td>
<td align="center">23</td>
<td align="center">Serum LBP</td>
<td align="center">32</td>
<td align="center">0.60, 0.62</td>
<td align="center">38 (14.0)</td>
<td align="center">79 (29.0)</td>
<td align="center">26 (9.6)</td>
<td align="center">129 (47.4)</td>
</tr>
<tr>
<td align="center"><bold>Tromp, M., et al., 2012 [</bold><xref ref-type="bibr" rid="pone.0153188.ref013">13</xref><bold>]</bold></td>
<td align="center">Prospective</td>
<td align="center">59/59</td>
<td align="center">ED</td>
<td align="center">55/287</td>
<td align="center">342</td>
<td align="center">16</td>
<td align="center">Plasma</td>
<td align="center">27.3</td>
<td align="center">0.60, 0.68</td>
<td align="center">33 (9.6)</td>
<td align="center">92 (26.9)</td>
<td align="center">22 (6.4)</td>
<td align="center">195 (57.1)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p><italic>Note</italic>. TP = True positive; FP = False positive; FN = False negative; TN = True negative</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="sec015">
<title>Results of Quality assessment</title>
<p><xref ref-type="table" rid="pone.0153188.t002">Table 2</xref> and <xref ref-type="fig" rid="pone.0153188.g002">Fig 2</xref> summarized the methodological quality assessment with the QUADAS-2 tool of the eight included studies. For the risk of bias in the reference standard, seven studies scored “low” since they used the criteria defined in the ACCP/SCCM consensus conference [<xref ref-type="bibr" rid="pone.0153188.ref022">22</xref>] as the gold standard. Regarding the domain of risk of bias in patient selection, six studies that provided a clear definition of the exclusion criteria and one study that only described the basic information about subjects without exclusion criteria were scored “low” and “high” risk, respectively. One study that did not show enough information regarding how they excluded patients was scored “unclear”. Regarding the domain of index test, it contains two terms, “Were the index test results interpreted without knowledge of the results of the reference standard?”, and “If a threshold was used, was it pre-specified”. If and only if the answers to these two terms were judged as “yes” indicating low risk of bias, otherwise, it was judged as high risk. In our included studies, seven studies did not pre-specify the threshold, so we decided to judge these studies to have “high” risk of bias regarding “Index test”. For patient flow and timing domains, seven studies scored “low” since they clearly defined the appropriate interval between the index test and reference standard in their studies. In relation to applicability, the reference standard domain scored well for seven of the eight included studies. Patient selection criteria in two studies were in accordance with our analysis inclusion criteria and scored“low”. The Cohens Kappa statistic for inter-rater agreement of assessment of quality was 0.37 (95% CI: 0.24–0.52). However, all disagreed evaluations were resolved after the consensus meeting.</p>
<table-wrap id="pone.0153188.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153188.t002</object-id>
<label>Table 2</label> <caption><title>Quality Assessment for 8 studies (QUADAS-2).</title></caption>
<alternatives>
<graphic id="pone.0153188.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center" rowspan="2">Study</th>
<th align="center" colspan="4">Risk of bias</th>
<th align="center" colspan="3">Applicability concerns</th>
</tr>
<tr>
<th align="center">Patient selection</th>
<th align="center">Index test</th>
<th align="center">Reference standard</th>
<th align="center">Flow and timing</th>
<th align="center">Patient selection</th>
<th align="center">Index test</th>
<th align="center">Reference standard</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center">Gaini, S., et al., 2007 [<xref ref-type="bibr" rid="pone.0153188.ref015">15</xref>]</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☺</td>
</tr>
<tr>
<td align="center">Gille-Johnson, P., et al., 2012 [<xref ref-type="bibr" rid="pone.0153188.ref014">14</xref>]</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">?</td>
<td align="center">☺</td>
<td align="center">?</td>
<td align="center">?</td>
<td align="center">?</td>
</tr>
<tr>
<td align="center">Meynaar, I.A., et al., 2011 [<xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>]</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☺</td>
</tr>
<tr>
<td align="center">Nierhaus, A., et al., 2013 [<xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>]</td>
<td align="center">☺</td>
<td align="center">?</td>
<td align="center">☺</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☹</td>
<td align="center">☺</td>
</tr>
<tr>
<td align="center">Prucha, M., et al., 2003 [<xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>]</td>
<td align="center">?</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☺</td>
<td align="center">☺</td>
<td align="center">☺</td>
<td align="center">☺</td>
</tr>
<tr>
<td align="center">Ratzinger, F., et al., 2013 [<xref ref-type="bibr" rid="pone.0153188.ref012">12</xref>]</td>
<td align="center">☹</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☺</td>
<td align="center">?</td>
<td align="center">☹</td>
<td align="center">☺</td>
</tr>
<tr>
<td align="center">Sakr, Y., et al., 2008 [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>]</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☺</td>
</tr>
<tr>
<td align="center">Tromp, M., et al., 2012 [<xref ref-type="bibr" rid="pone.0153188.ref013">13</xref>]</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
<td align="center">☹</td>
<td align="center">☺</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>☺ Low Risk ☹ High Risk ? Unclear Risk</p></fn>
</table-wrap-foot>
</table-wrap>
<fig id="pone.0153188.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153188.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Graphical Display of 8 studies results (QUADAS-2).</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec016">
<title>Results of quantitative data synthesis</title>
<p>The sensitivity reported by the eight studies ranged from 0.50–0.79, and the specificity ranged from 0.45–0.91. Pooled sensitivity and specificity estimates of all included studies obtained by the HSROC methods were 0.64 (95% CI: 0.56–0.72) and 0.63 (95% CI: 0.53–0.73), respectively (Figs <xref ref-type="fig" rid="pone.0153188.g003">3</xref> and <xref ref-type="fig" rid="pone.0153188.g004">4</xref>). We also constructed summary ROC for LBP, and the result showed the AUC of LBP to be 0.68 (95% CI: 0.64–0.72, <xref ref-type="fig" rid="pone.0153188.g004">Fig 4</xref>). The diagnostic odds ratio (DOR) of the included studies ranged from 2.39 (95% CI: 1.35–4.23) to 11.33 (95% CI: 3.28–39.18), and the pooled DOR was 3.0 (95% CI: 2.0–4.0), indicating a wide range and a poor level of overall accuracy. Our analysis indicated that serum LBP has a poor degree of diagnostic accuracy for sepsis.</p>
<fig id="pone.0153188.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153188.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Forest plots of the sensitivity and specificity for serum LBP level across all included studies.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.g003" xlink:type="simple"/>
</fig>
<fig id="pone.0153188.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153188.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Hierarchical summary receiver operating characteristic plot of serum LBP level across all included studies.</title>
<p>1: Axel Nierhaus 2013 [<xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>]; 2: Y.Sakr 2008 [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>]; 3: M.Prucha 2003 [<xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>]; 4: M.Tromp 2012 [<xref ref-type="bibr" rid="pone.0153188.ref013">13</xref>]; 5: S.Gaini 2007 [<xref ref-type="bibr" rid="pone.0153188.ref015">15</xref>]; 6: P.Gille-Johnson 2012 [<xref ref-type="bibr" rid="pone.0153188.ref014">14</xref>]; 7: Franz Ratzingerl 2013 [<xref ref-type="bibr" rid="pone.0153188.ref012">12</xref>]; 8: Iwan A.Meynaar 2011 [<xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>]</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.g004" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec017">
<title>Investigation of heterogeneity test</title>
<p>From visual inspection of the SROC curve (<xref ref-type="fig" rid="pone.0153188.g004">Fig 4</xref>) and the estimation of the Spearman correlation coefficient (ρ = -1.00, <italic>p</italic>-value &lt;0.001), we could conclude that threshold effect existed and contributed to the heterogeneity in our study. On the other hand, for the non-threshold effect, the heterogeneity was measured in the overall sensitivity (χ<sup>2</sup> = 71.31, <italic>p</italic>-value&lt;0.001, <italic>I</italic><sup>2</sup> = 71.31), specificity (χ<sup>2</sup> = 60.06, <italic>p</italic>-value&lt;0.001, <italic>I</italic><sup>2</sup> = 88.34), and DOR (Cochrane-Q = 21.81, <italic>p</italic>-value&lt;0.001, <italic>I</italic><sup>2</sup> = 44.07). Therefore, it indicated that threshold and non-threshold effects accounted for the high heterogeneity. We subsequently performed the bivariate meta-regression analysis to explore the source of heterogeneity. Mean age, patient source, patient sample size, proportion of patients with sepsis, types of specimen, and cut-off value were used as covariates. The results of bivariate meta-regression analysis (<xref ref-type="table" rid="pone.0153188.t003">Table 3</xref>) revealed that cut-off value accounted for the heterogeneity of sensitivity and sample size (&gt; = 150) accounted for the heterogeneity of specificity.</p>
<table-wrap id="pone.0153188.t003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153188.t003</object-id>
<label>Table 3</label> <caption><title>The results of univariable meta-regressions.</title></caption>
<alternatives>
<graphic id="pone.0153188.t003g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.t003" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="center"/>
<th align="center" colspan="3">Sensitivity</th>
<th align="center" colspan="3">Specificity</th>
</tr>
<tr>
<th align="center">Covariates</th>
<th align="center">Coefficient</th>
<th align="center">SE</th>
<th align="center"><italic>p</italic>-value</th>
<th align="center">Coefficient</th>
<th align="center">SE</th>
<th align="center"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center"><bold>Mean age</bold></td>
<td align="char" char=".">-0.001</td>
<td align="char" char=".">0.034</td>
<td align="char" char=".">0.968</td>
<td align="char" char=".">-0.007</td>
<td align="char" char=".">0.040</td>
<td align="char" char=".">0.854</td>
</tr>
<tr>
<td align="center"><bold>Patient source (ICU vs non-ICU)</bold></td>
<td align="char" char=".">0.570</td>
<td align="char" char=".">0.294</td>
<td align="char" char=".">0.053</td>
<td align="char" char=".">0.616</td>
<td align="char" char=".">0.348</td>
<td align="char" char=".">0.077</td>
</tr>
<tr>
<td align="center"><bold>Sample size (&gt; = 150)</bold></td>
<td align="char" char=".">0.472</td>
<td align="char" char=".">0.336</td>
<td align="char" char=".">0.160</td>
<td align="char" char=".">0.866</td>
<td align="char" char=".">0.382</td>
<td align="char" char=".">0.023</td>
</tr>
<tr>
<td align="center"><bold>Proportion of patients with sepsis (&gt;0.5)</bold></td>
<td align="char" char=".">0.623</td>
<td align="char" char=".">0.341</td>
<td align="char" char=".">0.068</td>
<td align="char" char=".">0.488</td>
<td align="char" char=".">0.495</td>
<td align="char" char=".">0.325</td>
</tr>
<tr>
<td align="center"><bold>Specimen</bold></td>
<td align="char" char=".">-0.276</td>
<td align="char" char=".">0.350</td>
<td align="char" char=".">0.430</td>
<td align="char" char=".">-0.213</td>
<td align="char" char=".">0.395</td>
<td align="char" char=".">0.590</td>
</tr>
<tr>
<td align="center"><bold>Cut-off</bold></td>
<td align="char" char=".">0.021</td>
<td align="char" char=".">0.009</td>
<td align="char" char=".">0.029</td>
<td align="char" char=".">0.015</td>
<td align="char" char=".">0.015</td>
<td align="char" char=".">0.315</td>
</tr>
</tbody>
</table>
</alternatives>
</table-wrap>
</sec>
<sec id="sec018">
<title>Results of subgroup analysis</title>
<p>In subgroup analysis, the results of patient sample size revealed that in the three studies [<xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] with smaller sample sizes (sample size&lt;150), the pooled sensitivity and specificity were 0.58 (95% CI: 0.45–0.69) and 0.77 (95% CI: 0.53–0.91), respectively, and in the other five studies [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0153188.ref015">15</xref>] with larger sample sizes (sample size&gt;150), the pooled sensitivity and specificity were 0.68 (95% CI: 0.58–0.77) and 0.57 (95% CI: 0.53–0.66), respectively.</p>
<p>We summarized the LBP cut-off values utilized in those studies in <xref ref-type="table" rid="pone.0153188.t001">Table 1</xref>. Cut-off values for serum LBP varied between studies, ranging from 18.2 to 64.6 μg/ml. We calculated the pooled sensitivity and specificity for these studies [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0153188.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] with similar cut-off values (ranged from 27.3 to 36 μg/ml). The pooled sensitivity and specificity were 0.61 (95% CI: 0.49–0.71) and 0.68 (95% CI: 0.53–0.80) for these five studies, respectively.</p>
<p>In relation to proportion of patients with sepsis, it demonstrated that in the six studies [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref012">12</xref>–<xref ref-type="bibr" rid="pone.0153188.ref014">14</xref>, <xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] with relatively lower proportion (&lt;50%), the pooled sensitivity and specificity were 0.61 (95% CI: 0.51–0.69) and 0.67 (95% CI: 0.55–0.77), respectively. Additionally, in relation to the reference standard, it demonstrated that in the seven studies [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>–<xref ref-type="bibr" rid="pone.0153188.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0153188.ref015">15</xref>, <xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] with the same gold standard (defined by the criteria defined in ACCP/SCCM consensus conference), the pooled sensitivity and specificity were 0.62 (95% CI: 0.53–0.70) and 0.65 (95% CI: 0.56–0.74), respectively.</p>
<p>Furthermore, among the included studies, four [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>, <xref ref-type="bibr" rid="pone.0153188.ref011">11</xref>, <xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] were conducted in the ICU, two [<xref ref-type="bibr" rid="pone.0153188.ref013">13</xref>, <xref ref-type="bibr" rid="pone.0153188.ref014">14</xref>] in the emergency department, and two [<xref ref-type="bibr" rid="pone.0153188.ref012">12</xref>, <xref ref-type="bibr" rid="pone.0153188.ref015">15</xref>] in the general ward. The pooled sensitivity and specificity were 0.58 (95% CI: 0.49–0.66) and 0.72 (95% CI: 0.54–0.85), respectively, in ICU patients, indicating a slightly better specificity. However, for the other four “non-critical” patients, the pooled sensitivity and specificity were 0.70 (95% CI: 0.59–0.79) and 0.56 (95% CI: 0.43–0.68), respectively, indicating a slightly better sensitivity.</p>
<p>We also performed subgroup analyses for the different types of specimen used to detect LBP concentrations. The pooled sensitivity and specificity were 0.62 (95% CI: 0.51–0.72) and 0.66 (95% CI: 0.50–0.80), respectively, for serum specimen. Otherwise, for plasma specimen, the pooled sensitivity and specificity were 0.66 (95% CI: 0.5–0.8) and 0.64 (95% CI: 0.54–0.72), respectively. The confidence intervals of the pooled sensitivity and specificity are seems completely overlapping for serum and plasma specimens.</p>
</sec>
<sec id="sec019">
<title>Results of publication bias</title>
<p><xref ref-type="fig" rid="pone.0153188.g005">Fig 5</xref> displays the Deeks’ effective sample size funnel plot and the regression test of asymmetry of the included studies. The Deeks’ test was not statistically significant (<italic>p</italic>-value = 0.18) indicating that there is no direct evidence for publication bias.</p>
<fig id="pone.0153188.g005" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0153188.g005</object-id>
<label>Fig 5</label>
<caption>
<title>Deeks’ funnel plot asymmetry test for publication bias.</title>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.g005" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec020" sec-type="conclusions">
<title>Discussion</title>
<p>It is critical to identify sepsis early in the clinical course to provide timely and accurate treatment for patients. Clinical assessment or non-specific criteria such as SIRS alone cannot satisfy this purpose. Diagnosis of sepsis is still largely based on SIRS in the presence of an infectious focus. SIRS, purposed since the consensus meeting in 1992, was originally developed for research purposes, and is neither sensitive nor specific in diagnosing sepsis. Furthermore, other than sepsis, SIRS can be found in various non-septic conditions, including trauma, surgery, and pancreatitis [<xref ref-type="bibr" rid="pone.0153188.ref023">23</xref>, <xref ref-type="bibr" rid="pone.0153188.ref024">24</xref>]. There is consensus regarding the need to develop an ideal marker of sepsis, which can be measured rapidly and easily, sensitive enough to detect infection in patients, and specific enough to rule out non-infectious SIRS [<xref ref-type="bibr" rid="pone.0153188.ref025">25</xref>].</p>
<p>A growing number of studies suggest that LBP may play a role in identifying sepsis, and our study summarizes the overall diagnostic performance of LBP for sepsis based on the current available literature. To our knowledge, this is the first systematic review and meta-analysis to summary this biomarker, Lipopolysaccharide- Binding Protein (LBP), in diagnosis of adult patients with sepsis. Our results reveal that the pooled sensitivity of serum LBP for the diagnosis of sepsis to be sub-optimal (pooled sensitivity 0.64 and pooled specificity 0.63). The AUC used to summarize the overall diagnostic performance of the included studies was not satisfactory (0.68). In this meta-analysis, our pooled analysis indicated that serum LBP seemed to have a moderate to low diagnostic accuracy for sepsis.</p>
<p>The DOR combines the strengths of sensitivity and specificity, and has the advantage of accuracy as a single indicator, with higher values indicating the highest accuracy. In this meta-analysis, the DOR of the included studies ranged from 2.39 (95% CI: 1.35–4.23) to 11.33 (95% CI: 3.28–39.18), and the pooled DOR was 3.0 (95% CI: 2.0–4.0), indicating a wide range and a low level of overall accuracy. In Wu et al. [<xref ref-type="bibr" rid="pone.0153188.ref026">26</xref>], they suggest that the disparity between these included studies may result from the patient sample size variations. Song F. et al. [<xref ref-type="bibr" rid="pone.0153188.ref027">27</xref>] was suggested that small studies tend to overestimate the DOR and studies based on small sample sizes may have allowed higher type II errors.</p>
<p>There are several other sources that may cause the heterogeneity of the included studies surveying the performance of LBP in our study. The specificity of LBP seemed to be slightly better in the ICU setting (0.72), low sepsis prevalence (0.67), and smaller sample size (0.71) from our results of subgroup analyses. Furthermore, the pooled sensitivity of LBP seemed to be slightly better in the non-critical setting (0.70). There are studies [<xref ref-type="bibr" rid="pone.0153188.ref007">7</xref>–<xref ref-type="bibr" rid="pone.0153188.ref009">9</xref>] supporting LBP as an early biomarker for sepsis, which could be the reason why LBP has the better specificity in ICU setting.</p>
<p>Several biomarkers including procalcitonin (PCT) and C-reactive protein (CRP) are already available for clinical use to diagnose sepsis; however, their effectiveness in distinguishing sepsis from other inflammatory or for predicting outcome is limited by their far from perfect specificity and sensitivity. A clinical study performed by Meynaar et al. [<xref ref-type="bibr" rid="pone.0153188.ref016">16</xref>] showed that PCT was more useful (the area under the ROC curve (0.95, 95% CI: 0.90–0.99)) than LBP, CRP, and IL-6 in differentiating sepsis from SIRS in critically ill patients admitted to hospital. However, a recent meta-analysis published by Wacker et al. [<xref ref-type="bibr" rid="pone.0153188.ref028">28</xref>], concluded that the accuracy of PCT to discriminate sepsis and SIRS was sub-optimal as well, and the sensitivity and specificity of PCT in diagnosing sepsis were 0.77 (95% CI 0.72–0.81) and 0.79 (95% CI 0.74–0.84), respectively. Due to the complexity of the sepsis response, current methods and biomarkers used for the diagnosis of sepsis remain unsatisfactory [<xref ref-type="bibr" rid="pone.0153188.ref029">29</xref>], and more reliable diagnostic markers are needed.</p>
<p>Recently, many biomarkers have been proposed for use in sepsis diagnosis. However, none has sufficient sensitivity or specificity to be the single test able to distinguish sepsis from other inflammatory conditions. In view of the complexity of the sepsis response, it is unlikely that a single ideal biomarker will ever be found to diagnose sepsis [<xref ref-type="bibr" rid="pone.0153188.ref030">30</xref>]. From the results of Gibot et al. [<xref ref-type="bibr" rid="pone.0153188.ref031">31</xref>], they suggested that a combination of several biomarkers, such as the PMN CD64 index, PCT, and sTREM-1, may be more effective to improve diagnostic accuracy for sepsis. From the view of their suggestion, we may combine the measurement of LBP with other more sensitive biomarkers to increase the diagnostic accuracy for sepsis although LBP has a weak important role in diagnosing sepsis from our meta-analysis.</p>
<p>This systematic review and meta-analysis had several limitations that should be discussed. First, the number of included studies for LBP was still small, although an extensive literature search was conducted. We included only eight studies published because of our strict inclusion criteria. Owing to the clinical and statistical heterogeneity, our study may have lacked statistical power to draw a definite conclusion, and more clinical diagnostic studies are needed to reach a final conclusion. Second, there are risks of bias regarding patient misclassification, since the reference standard utilized in these included studies varied in the patients who were clinically diagnosed as having sepsis without microbiological evidence. Third, we could not determine the ideal cut-off point for serum LBP test in the meta-analysis, since we did not have the raw data to map out the ROC curve. To determine whether there is a single threshold or a few important thresholds, further studies should be attempted to obtain all the original data. Finally, we only included studies published in English, which may have resulted in language bias, and the inclusion of other language publication or studies with null results may have yielded different results.</p>
</sec>
<sec id="sec021" sec-type="conclusions">
<title>Conclusions</title>
<p>Our systematic review summarizes evidence regarding the diagnostic accuracy of LBP as a biomarker for sepsis in adult patients. Based on the results of our meta-analysis, LBP had weak sensitivity and specificity. LBP may not be practically recommended for clinical utilization as a single biomarker.</p>
</sec>
<sec id="sec022">
<title>Supporting Information</title>
<supplementary-material id="pone.0153188.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0153188.s001" xlink:type="simple">
<label>S1 PRISMA Checklist</label>
<caption>
<title>Prisma checklist.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The study was supported by the National Science Council and Chang Gung Memorial Hospital in Taiwan (100-2314-B-182A-038-MY3, CMRPG2C0201, CMRPG2B0121, CMRPG2B0271 and CMRPG2B0371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0153188.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martin</surname> <given-names>GS</given-names></name>, <name name-style="western"><surname>Mannino</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Eaton</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Moss</surname> <given-names>M</given-names></name>. <article-title>The epidemiology of sepsis in the United States from 1979 through 2000</article-title>. <source>N Engl J Med</source>. <year>2003</year>;<volume>348</volume>(<issue>16</issue>):<fpage>1546</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa022139" xlink:type="simple">10.1056/NEJMoa022139</ext-link></comment> <object-id pub-id-type="pmid">12700374</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tobias</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Soldau</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Ulevitch</surname> <given-names>RJ</given-names></name>. <article-title>Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum</article-title>. <source>J Exp Med</source>. <year>1986</year>;<volume>164</volume>(<issue>3</issue>):<fpage>777</fpage>–<lpage>93</lpage>. <object-id pub-id-type="pmid">2427635</object-id>; PubMed Central PMCID: PMCPMC2188379.</mixed-citation></ref>
<ref id="pone.0153188.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wurfel</surname> <given-names>MM</given-names></name>, <name name-style="western"><surname>Kunitake</surname> <given-names>ST</given-names></name>, <name name-style="western"><surname>Lichenstein</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kane</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Wright</surname> <given-names>SD</given-names></name>. <article-title>Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS</article-title>. <source>J Exp Med</source>. <year>1994</year>;<volume>180</volume>(<issue>3</issue>):<fpage>1025</fpage>–<lpage>35</lpage>. <object-id pub-id-type="pmid">8064223</object-id>; PubMed Central PMCID: PMCPMC2191628.</mixed-citation></ref>
<ref id="pone.0153188.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Blairon</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Wittebole</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Laterre</surname> <given-names>PF</given-names></name>. <article-title>Lipopolysaccharide-binding protein serum levels in patients with severe sepsis due to gram-positive and fungal infections</article-title>. <source>J Infect Dis</source>. <year>2003</year>;<volume>187</volume>(<issue>2</issue>):<fpage>287</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/346046" xlink:type="simple">10.1086/346046</ext-link></comment> <object-id pub-id-type="pmid">12552453</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guha</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mackman</surname> <given-names>N</given-names></name>. <article-title>LPS induction of gene expression in human monocytes</article-title>. <source>Cell Signal</source>. <year>2001</year>;<volume>13</volume>(<issue>2</issue>):<fpage>85</fpage>–<lpage>94</lpage>. <object-id pub-id-type="pmid">11257452</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wright</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Ramos</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Tobias</surname> <given-names>PS</given-names></name>, <name name-style="western"><surname>Ulevitch</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Mathison</surname> <given-names>JC</given-names></name>. <article-title>CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein</article-title>. <source>Science</source>. <year>1990</year>;<volume>249</volume>(<issue>4975</issue>):<fpage>1431</fpage>–<lpage>3</lpage>. <object-id pub-id-type="pmid">1698311</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakr</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Burgett</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Nacul</surname> <given-names>FE</given-names></name>, <name name-style="western"><surname>Reinhart</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Brunkhorst</surname> <given-names>F</given-names></name>. <article-title>Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?</article-title> <source>Crit Care Med</source>. <year>2008</year>;<volume>36</volume>(<issue>7</issue>):<fpage>2014</fpage>–<lpage>22</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1097/CCM.0b013e31817b86e3" xlink:type="simple">10.1097/CCM.0b013e31817b86e3</ext-link></comment> <object-id pub-id-type="pmid">18552695</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Opal</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Scannon</surname> <given-names>PJ</given-names></name>, <name name-style="western"><surname>Vincent</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Carroll</surname> <given-names>SF</given-names></name>, <name name-style="western"><surname>Palardy</surname> <given-names>JE</given-names></name>, <etal>et al</etal>. <article-title>Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock</article-title>. <source>J Infect Dis</source>. <year>1999</year>;<volume>180</volume>(<issue>5</issue>):<fpage>1584</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/315093" xlink:type="simple">10.1086/315093</ext-link></comment> <object-id pub-id-type="pmid">10515819</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Prucha</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Herold</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Zazula</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Dubska</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Dostal</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hildebrand</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients</article-title>. <source>Crit Care</source>. <year>2003</year>;<volume>7</volume>(<issue>6</issue>):<fpage>R154</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/cc2386" xlink:type="simple">10.1186/cc2386</ext-link></comment> <object-id pub-id-type="pmid">14624690</object-id>; PubMed Central PMCID: PMCPMC374378.</mixed-citation></ref>
<ref id="pone.0153188.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gaini</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Koldkjaer</surname> <given-names>OG</given-names></name>, <name name-style="western"><surname>Pedersen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pedersen</surname> <given-names>SS</given-names></name>. <article-title>Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study</article-title>. <source>Crit Care</source>. <year>2006</year>;<volume>10</volume>(<issue>2</issue>):<fpage>R53</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/cc4866" xlink:type="simple">10.1186/cc4866</ext-link></comment> <object-id pub-id-type="pmid">16569262</object-id>; PubMed Central PMCID: PMCPMC1550885.</mixed-citation></ref>
<ref id="pone.0153188.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nierhaus</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Klatte</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Linssen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Eismann</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Wichmann</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Hedke</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis—a prospective, observational study</article-title>. <source>BMC Immunol</source>. <year>2013</year>;<volume>14</volume>:<fpage>8</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2172-14-8" xlink:type="simple">10.1186/1471-2172-14-8</ext-link></comment> <object-id pub-id-type="pmid">23398965</object-id>; PubMed Central PMCID: PMCPMC3575223.</mixed-citation></ref>
<ref id="pone.0153188.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ratzinger</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Schuardt</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Eichbichler</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tsirkinidou</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Bauer</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Haslacher</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>12</issue>):<fpage>e82946</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0082946" xlink:type="simple">10.1371/journal.pone.0082946</ext-link></comment> <object-id pub-id-type="pmid">24349403</object-id>; PubMed Central PMCID: PMCPMC3859603.</mixed-citation></ref>
<ref id="pone.0153188.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tromp</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lansdorp</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Bleeker-Rovers</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Gunnewiek</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Kullberg</surname> <given-names>BJ</given-names></name>, <name name-style="western"><surname>Pickkers</surname> <given-names>P</given-names></name>. <article-title>Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement</article-title>. <source>J Infect</source>. <year>2012</year>;<volume>65</volume>(<issue>4</issue>):<fpage>292</fpage>–<lpage>301</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jinf.2012.06.004" xlink:type="simple">10.1016/j.jinf.2012.06.004</ext-link></comment> <object-id pub-id-type="pmid">22710263</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gille-Johnson</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hansson</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Gardlund</surname> <given-names>B</given-names></name>. <article-title>Clinical and laboratory variables identifying bacterial infection and bacteraemia in the emergency department</article-title>. <source>Scand J Infect Dis</source>. <year>2012</year>;<volume>44</volume>(<issue>10</issue>):<fpage>745</fpage>–<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3109/00365548.2012.689846" xlink:type="simple">10.3109/00365548.2012.689846</ext-link></comment> <object-id pub-id-type="pmid">22803656</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gaini</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Koldkjaer</surname> <given-names>OG</given-names></name>, <name name-style="western"><surname>Moller</surname> <given-names>HJ</given-names></name>, <name name-style="western"><surname>Pedersen</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pedersen</surname> <given-names>SS</given-names></name>. <article-title>A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study</article-title>. <source>Crit Care</source>. <year>2007</year>;<volume>11</volume>(<issue>4</issue>):<fpage>R76</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/cc5967" xlink:type="simple">10.1186/cc5967</ext-link></comment> <object-id pub-id-type="pmid">17625012</object-id>; PubMed Central PMCID: PMCPMC2206511.</mixed-citation></ref>
<ref id="pone.0153188.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meynaar</surname> <given-names>IA</given-names></name>, <name name-style="western"><surname>Droog</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Batstra</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Vreede</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Herbrink</surname> <given-names>P</given-names></name>. <article-title>In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP</article-title>. <source>Crit Care Res Pract</source>. <year>2011</year>;<volume>2011</volume>:<fpage>594645</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2011/594645" xlink:type="simple">10.1155/2011/594645</ext-link></comment> <object-id pub-id-type="pmid">21687569</object-id>; PubMed Central PMCID: PMCPMC3113363.</mixed-citation></ref>
<ref id="pone.0153188.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Landis</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Koch</surname> <given-names>GG</given-names></name>. <article-title>The measurement of observer agreement for categorical data</article-title>. <source>Biometrics</source>. <year>1977</year>;<volume>33</volume>(<issue>1</issue>):<fpage>159</fpage>–<lpage>74</lpage>. <object-id pub-id-type="pmid">843571</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Whiting</surname> <given-names>PF</given-names></name>, <name name-style="western"><surname>Rutjes</surname> <given-names>AW</given-names></name>, <name name-style="western"><surname>Westwood</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Mallett</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Deeks</surname> <given-names>JJ</given-names></name>, <name name-style="western"><surname>Reitsma</surname> <given-names>JB</given-names></name>, <etal>et al</etal>. <article-title>QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies</article-title>. <source>Ann Intern Med</source>. <year>2011</year>;<volume>155</volume>(<issue>8</issue>):<fpage>529</fpage>–<lpage>36</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009" xlink:type="simple">10.7326/0003-4819-155-8-201110180-00009</ext-link></comment> <object-id pub-id-type="pmid">22007046</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rutter</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Gatsonis</surname> <given-names>CA</given-names></name>. <article-title>A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations</article-title>. <source>Stat Med</source>. <year>2001</year>;<volume>20</volume>(<issue>19</issue>):<fpage>2865</fpage>–<lpage>84</lpage>. <object-id pub-id-type="pmid">11568945</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moses</surname> <given-names>LE</given-names></name>, <name name-style="western"><surname>Shapiro</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Littenberg</surname> <given-names>B</given-names></name>. <article-title>Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations</article-title>. <source>Stat Med</source>. <year>1993</year>;<volume>12</volume>(<issue>14</issue>):<fpage>1293</fpage>–<lpage>316</lpage>. <object-id pub-id-type="pmid">8210827</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>SG</given-names></name>. <article-title>Quantifying heterogeneity in a meta-analysis</article-title>. <source>Stat Med</source>. <year>2002</year>;<volume>21</volume>(<issue>11</issue>):<fpage>1539</fpage>–<lpage>58</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/sim.1186" xlink:type="simple">10.1002/sim.1186</ext-link></comment> <object-id pub-id-type="pmid">12111919</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bone</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Balk</surname> <given-names>RA</given-names></name>, <name name-style="western"><surname>Cerra</surname> <given-names>FB</given-names></name>, <name name-style="western"><surname>Dellinger</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Fein</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Knaus</surname> <given-names>WA</given-names></name>, <etal>et al</etal>. <article-title>Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine</article-title>. <source>Chest</source>. <year>1992</year>;<volume>101</volume>(<issue>6</issue>):<fpage>1644</fpage>–<lpage>55</lpage>. <object-id pub-id-type="pmid">1303622</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adib-Conquy</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Cavaillon</surname> <given-names>JM</given-names></name>. <article-title>Stress molecules in sepsis and systemic inflammatory response syndrome</article-title>. <source>FEBS Lett</source>. <year>2007</year>;<volume>581</volume>(<issue>19</issue>):<fpage>3723</fpage>–<lpage>33</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.febslet.2007.03.074" xlink:type="simple">10.1016/j.febslet.2007.03.074</ext-link></comment> <object-id pub-id-type="pmid">17428476</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rangel-Frausto</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Pittet</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Costigan</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hwang</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Davis</surname> <given-names>CS</given-names></name>, <name name-style="western"><surname>Wenzel</surname> <given-names>RP</given-names></name>. <article-title>The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study</article-title>. <source>JAMA</source>. <year>1995</year>;<volume>273</volume>(<issue>2</issue>):<fpage>117</fpage>–<lpage>23</lpage>. <object-id pub-id-type="pmid">7799491</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Carlet</surname> <given-names>J</given-names></name>. <article-title>Rapid diagnostic methods in the detection of sepsis</article-title>. <source>Infect Dis Clin North Am</source>. <year>1999</year>;<volume>13</volume>(<issue>2</issue>):<fpage>483</fpage>–<lpage>94</lpage>, <fpage>xi</fpage>. <object-id pub-id-type="pmid">10340179</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Fan</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Bao</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Bo</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Li</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Accuracy of plasma sTREM-1 for sepsis diagnosis in systemic inflammatory patients: a systematic review and meta-analysis</article-title>. <source>Crit Care</source>. <year>2012</year>;<volume>16</volume>(<issue>6</issue>):<fpage>R229</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/cc11884" xlink:type="simple">10.1186/cc11884</ext-link></comment> <object-id pub-id-type="pmid">23194114</object-id>; PubMed Central PMCID: PMCPMC3672614.</mixed-citation></ref>
<ref id="pone.0153188.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Song</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Khan</surname> <given-names>KS</given-names></name>, <name name-style="western"><surname>Dinnes</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Sutton</surname> <given-names>AJ</given-names></name>. <article-title>Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy</article-title>. <source>Int J Epidemiol</source>. <year>2002</year>;<volume>31</volume>(<issue>1</issue>):<fpage>88</fpage>–<lpage>95</lpage>. <object-id pub-id-type="pmid">11914301</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wacker</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Prkno</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Brunkhorst</surname> <given-names>FM</given-names></name>, <name name-style="western"><surname>Schlattmann</surname> <given-names>P</given-names></name>. <article-title>Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis</article-title>. <source>Lancet Infect Dis</source>. <year>2013</year>;<volume>13</volume>(<issue>5</issue>):<fpage>426</fpage>–<lpage>35</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1473-3099(12)70323-7" xlink:type="simple">10.1016/S1473-3099(12)70323-7</ext-link></comment> <object-id pub-id-type="pmid">23375419</object-id>.</mixed-citation></ref>
<ref id="pone.0153188.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Henriquez-Camacho</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Losa</surname> <given-names>J</given-names></name>. <article-title>Biomarkers for sepsis</article-title>. <source>Biomed Res Int</source>. <year>2014</year>;<volume>2014</volume>:<fpage>547818</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1155/2014/547818" xlink:type="simple">10.1155/2014/547818</ext-link></comment> <object-id pub-id-type="pmid">24800240</object-id>; PubMed Central PMCID: PMCPMC3985161.</mixed-citation></ref>
<ref id="pone.0153188.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pierrakos</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vincent</surname> <given-names>JL</given-names></name>. <article-title>Sepsis biomarkers: a review</article-title>. <source>Crit Care</source>. <year>2010</year>;<volume>14</volume>(<issue>1</issue>):<fpage>R15</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/cc8872" xlink:type="simple">10.1186/cc8872</ext-link></comment> <object-id pub-id-type="pmid">20144219</object-id>; PubMed Central PMCID: PMCPMC2875530.</mixed-citation></ref>
<ref id="pone.0153188.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibot</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bene</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Noel</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Massin</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Guy</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cravoisy</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Combination biomarkers to diagnose sepsis in the critically ill patient</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2012</year>;<volume>186</volume>(<issue>1</issue>):<fpage>65</fpage>–<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1164/rccm.201201-0037OC" xlink:type="simple">10.1164/rccm.201201-0037OC</ext-link></comment> <object-id pub-id-type="pmid">22538802</object-id>.</mixed-citation></ref>
</ref-list>
</back>
</article>